Treatment of Oral Cavity Cancer in Metastatic or Recurrent Lip and Oral Cavity Disease
Clinical Scenario
This protocol addresses patients with metastatic or recurrent lip and oral cavity cancer — a setting where disease has returned or spread beyond its original site, and the clinical approach must account for the patient's prior treatment history and the specific location and extent of recurrence.
Disease Presentation
For lesions of the lip, anterior tongue, buccal mucosa, floor of the mouth, retromolar trigone, upper gingiva, and hard palate, treatment is dictated by the location and size of the recurrent lesion as well as prior treatment received.
Treatment Approach (Partial)
Systemic chemotherapy is part of the approach for this setting and has been shown to induce responses in metastatic or recurrent oral cavity cancer.
The complete regimen, options, and sequencing are available in the full protocol →
References
- For lesions of the lip, anterior tongue, buccal mucosa, floor of the mouth, retromolar trigone, upper gingiva, and hard palate, treatment is dictated by the location and size of the recurrent lesion as well as prior treatment.
- Although chemotherapy has been shown to induce responses, no increase in survival has been demonstrated.
View source ↗